| scholarly article | Q13442814 |
| P2093 | author name string | Heusch G | |
| Lee JD | |||
| Katayama K | |||
| Ross J Jr | |||
| Guth BD | |||
| Seitelberger R | |||
| P433 | issue | 3 | |
| P304 | page(s) | 436-442 | |
| P577 | publication date | 1988-03-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise | |
| P478 | volume | 62 |
| Q46442390 | Alpha 1-adrenergic blockade reduces exercise-induced regional myocardial ischemia in dogs |
| Q40543476 | Alpha 1-adrenergic tone does not influence the transmural distribution of myocardial blood flow during exercise in dogs with pressure overload left ventricular hypertrophy. |
| Q44283299 | Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytes |
| Q40498053 | Alpha-adrenergic control of coronary circulation in man. |
| Q77766231 | Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries |
| Q43893156 | Alpha-adrenoceptor subtypes and regional myocardial blood flow distribution during coronary occlusion in dogs |
| Q44772702 | Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus |
| Q38018510 | Calcium antagonists in myocardial ischemia/reperfusion--update 2012. |
| Q78569988 | Can the premises of the spasm of resistance vessel concept permit improvement in the treatment and prevention of ischemic heart disease? |
| Q64933090 | Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection. |
| Q50999338 | Changes in cardiac autonomic activities in patients with syndrome X. A study of spectral analysis of heart rate variability. |
| Q71519139 | Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective coronary artery bypass grafting |
| Q51565467 | Coronary vascular effects of dexmedetomidine during reactive hyperemia in the anesthetized dog. |
| Q70863094 | Effects of alpha-adrenergic blockade on regional myocardial function in canine ischemic myocardium during beta-adrenergic blockade |
| Q51424543 | Effects of the specific bradycardic agent zatebradine on hemodynamic variables and myocardial blood flow during the early postresuscitation phase in pigs. |
| Q78818561 | Emerging importance of alpha-adrenergic coronary vasoconstriction in acute coronary syndromes and its genetic background |
| Q49711802 | Exaggerated coronary vasoconstriction limits muscle metaboreflex-induced increases in ventricular performance in hypertension. |
| Q72681896 | Exercise tolerance in angina is improved by mivazerol--an alpha 2-adrenoceptor agonist |
| Q68166920 | Felodipine prevents the poststenotic myocardial ischemia induced by alpha 2-adrenergic coronary constriction |
| Q49917885 | Guidelines for Experimental Models of Myocardial Ischemia and Infarction |
| Q37068649 | Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents |
| Q37868929 | Heart rate: a forgotten link in coronary artery disease? |
| Q46487346 | Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction |
| Q37782864 | Increased coronary tone in exertional angina: the beneficial effects of calcium antagonists |
| Q38986970 | Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention |
| Q38797276 | Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction |
| Q35328248 | Management of angina pectoris. Modern concepts |
| Q35819031 | Matching coronary blood flow to myocardial oxygen consumption. |
| Q45024949 | Minimal alpha 1- and alpha 2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine |
| Q40465930 | Neuronal control of coronary blood flow |
| Q40543470 | No adrenergic constriction in isolated coronary arterioles? |
| Q53637670 | Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and Ivabradine. |
| Q38215906 | Pharmacological mechanisms to attenuate sympathetically induced myocardial ischemia |
| Q38378869 | Pharmacology of acute effort angina |
| Q37988319 | Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain. |
| Q42205768 | Pleiotropic, heart rate-independent cardioprotection by ivabradine. |
| Q37216075 | Regulation of coronary blood flow during exercise |
| Q83659593 | Reprint of: the paradox of α-adrenergic coronary vasoconstriction revisited |
| Q45182710 | Role of endothelin in alpha-adrenoceptor coronary vasoconstriction. |
| Q58994299 | The Coronary Microcirculation in Health and Disease |
| Q37860513 | The paradox of α-adrenergic coronary vasoconstriction revisited |
| Q41284829 | The renin-angiotensin system and coronary vasomotion |
| Q34730803 | Yohimbine promotes cardiac NE release and prevents LPS-induced cardiac dysfunction via blockade of presynaptic α2A-adrenergic receptor |
Search more.